Ironwood Pharmaceuticals, Inc.

NASDAQ:IRWD

Drug Manufacturers - Specialty & Generic

Healthcare
$4.78 +0.14%

+$0.01 today

Market cap
$791.33M
Beta
0.24
P/E (TTM)
5.6
EPS (TTM)
$0.63
52W Low $0.66High $5.78

Volume 2.22M

Average 2.35M

IRWD Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

Ironwood Pharmaceuticals, Inc.NASDAQ: IRWD

Net Debt · Q1 FY2026 · quarter ended Mar 2026

Net debt falls 23.2% from a year ago

Net debt stood at $376.89M at the end of Q1 FY2026, down 23.2% from a year earlier and down 1.4% from the prior quarter.

Context

  • Net debt amounted to 86.7% of total assets at the end of Q1 FY2026, down 63.2 pp from a year earlier.
  • Net debt increased in 1 of the last 3 fiscal years.

What to watch

Whether net debt keeps falling in the next quarterly balance sheet after a -23.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$376.89M-1.4% QoQ
Last fiscal yearDec 2025
$382.35M-25.2% YoY
Year agoMar 2025
$490.6M-23.2% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-23.2%——
1 year-25.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
382.35M USD
Year-over-year change
-25.2%

Net Debt vs competitors

How IRWD compares with its peers on the latest reported figures

  • IRWD's Mar 2026 net debt of $376.89M is the highest of the 3 companies compared; the peer median is $47.16M.
  • Its year-over-year change of -23.2% is the 2nd highest of 3, against a peer median of +7.5%.
  • Net debt amounts to 86.7% of total assets for IRWD, versus a peer median of 21.3%.
IRWD Competitors Peer median
Net Debt for IRWD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IRWDIronwood Pharmaceuticals, Inc.Mar 2026$376.89M -23.2%—86.7%
ARDXArdelyx, Inc.Mar 2026$177.06M +42.4%—35.1%
SYRESpyre Therapeutics, Inc.Sep 2026-$82.73M -27.5%—7.5%
Peer median (excluding IRWD) $47.16M+7.5%—21.3%

Competitors are the stored peer set for IRWD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents620.13M656.2M92.15M88.56M215.46M
Short-term Investments00000
Net Receivables114.04M115.46M129.12M81.89M46.75M
Inventory01.25M000
Other Current Assets2.37M0011.92M11.98M
Total Current Assets745.23M780.63M233.29M182.37M274.18M
Property, Plant & Equipment (Net)22.93M20.31M18.17M15.52M12.75M
Goodwill00000
Intangible Assets003.68M2.86M2.04M
Long-term Investments015.07M000
Tax Assets333.29M283.66M212.32M144.23M103.43M
Other Non-current Assets25.48M847K3.61M5.92M4.5M
Total Non-current Assets381.7M319.89M237.79M168.54M122.72M
Total Assets1.13B1.1B471.07M350.91M396.9M
Account Payables935K483K7.83M2.13M2.9M
Short-term Debt116.86M0199.56M0199.68M
Tax Payables0656K1.24M521K0
Deferred Revenue002.62M2.03M1.11M
Other Current Liabilities7.49M15.88M26.13M4.98M21M
Total Current Liabilities161.7M25.53M276.1M38.85M242.22M
Long-term Debt337.33M396.25M498.31M583.99M385M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities3.5M9.77M28.42M17.11M21.65M
Total Non-current Liabilities359.32M422.62M541.27M613.4M416.52M
Total Liabilities521.02M448.14M817.37M652.24M658.74M
Common Stock162K154K156K160K163K
Retained Earnings(937.61M)(696.38M)(1.7B)(1.7B)(1.67B)
Accumulated OCI(0)0(3.03M)923K(1.06M)
Other Stockholders Equity0(0)000
Minority Interest00000
Total Equity605.91M652.38M(346.3M)(301.34M)(261.83M)
Total Debt475.8M415.92M715.54M599.48M597.8M
Net Debt(144.33M)(240.29M)623.38M510.92M382.35M

Ironwood Pharmaceuticals, Inc.

NASDAQ:IRWD

Intrinsic Alpha fair value

Locked

Current Price

$4.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.